Advancing Antibody Therapeutics to the Clinic
Antibody therapies are advancing to clinical development for cancer and results to date are extremely encouraging. The oncology stream will focus on identifying emerging targets, investigating novel constructs including ADCs and bispecific antibodies,
and highlighting approaches for combination therapies. The Oncology stream will explore the latest trends and comparing strategies and recent successes from discovery to preclinical and clinical development.